First federal grant for psychedelic treatment research in 50 years (hopkinsmedicine.org)

Article summary

The article discusses a federal grant for psychedelic treatment research, which will be conducted simultaneously at three institutions to diversify the pool of participants and increase confidence in the results. The study aims to investigate the potential therapeutic benefits of psychedelics. The comments reveal that this is the first federal grant for such research in 50 years, indicating a shift in attitudes towards psychedelic research. The study's design and operation are considered thoughtful and professional.

Main themes

• psychedelic research
• federal grant
• therapeutic potential
• risk and safety
• history of psychedelic research
• ethics of experimentation
• controlled substances
• alcohol comparison
• responsible research
• nuanced evaluation

What commenters say

• Some commenters believe that psychedelics have the potential to be a miracle cure for certain diseases, but their development has been hindered by restrictive policies.
• Others argue that psychedelics can be dangerous and have the potential to trigger major changes in personality or latent mental illnesses.
• The dangers of psychedelics are compared to those of alcohol, with some arguing that the risks are overstated and others pointing out that the risks are different in nature.
• There is a debate about the ethics of past experiments involving psychedelics, with some considering them to be irresponsible and others arguing that they contributed to our understanding of human behavior.
• The role of figures like Leary and Shulgin in the history of psychedelic research is also discussed, with some blaming them for setting back the field and others seeing them as pioneers.
• Some commenters emphasize the importance of responsible and controlled research into psychedelics, while others argue that the risks are too great.
• The comparison between the dangers of psychedelics and other substances, such as alcohol, is also a point of contention.
• There is a discussion about the need to re-evaluate the risks and benefits of psychedelics in a nuanced and evidence-based way.